Michael E. Feigin

3.4k total citations
26 papers, 914 citations indexed

About

Michael E. Feigin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Michael E. Feigin has authored 26 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Michael E. Feigin's work include Pancreatic and Hepatic Oncology Research (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Receptor Mechanisms and Signaling (6 papers). Michael E. Feigin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and Receptor Mechanisms and Signaling (6 papers). Michael E. Feigin collaborates with scholars based in United States, Canada and Saudi Arabia. Michael E. Feigin's co-authors include Craig C. Malbon, Senthil K. Muthuswamy, Rama Kamesh Bikkavilli, Bin Xue, Molly Hammell, Avi Z. Rosenberg, Jennifer A. Pietenpol, S. Dipikaa Akshinthala, Brian D. Lehmann and Hal K. Berman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and PLoS ONE.

In The Last Decade

Michael E. Feigin

24 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Feigin United States 16 708 214 180 119 66 26 914
Tadahiro Nagaoka United States 17 773 1.1× 301 1.4× 224 1.2× 117 1.0× 79 1.2× 31 972
Agata Zieba Sweden 16 520 0.7× 192 0.9× 210 1.2× 116 1.0× 59 0.9× 22 922
Angela Russo United States 20 537 0.8× 142 0.7× 141 0.8× 141 1.2× 45 0.7× 38 1.0k
Xianghu Qu United States 15 916 1.3× 173 0.8× 104 0.6× 148 1.2× 64 1.0× 26 1.2k
Satoko Ito Japan 21 779 1.1× 234 1.1× 217 1.2× 216 1.8× 36 0.5× 47 1.1k
Anthony Makkinje United States 13 794 1.1× 186 0.9× 167 0.9× 87 0.7× 51 0.8× 15 1.1k
María Élida Scassa Argentina 17 591 0.8× 223 1.0× 90 0.5× 139 1.2× 63 1.0× 36 881
Hashem A. Dbouk United States 13 696 1.0× 130 0.6× 140 0.8× 64 0.5× 48 0.7× 20 916
Georgia Mavria United Kingdom 16 780 1.1× 238 1.1× 275 1.5× 187 1.6× 65 1.0× 29 1.2k
Delphine Fessart France 18 638 0.9× 173 0.8× 334 1.9× 148 1.2× 109 1.7× 28 977

Countries citing papers authored by Michael E. Feigin

Since Specialization
Citations

This map shows the geographic impact of Michael E. Feigin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Feigin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Feigin more than expected).

Fields of papers citing papers by Michael E. Feigin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Feigin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Feigin. The network helps show where Michael E. Feigin may publish in the future.

Co-authorship network of co-authors of Michael E. Feigin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Feigin. A scholar is included among the top collaborators of Michael E. Feigin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Feigin. Michael E. Feigin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reavis, Hunter D., et al.. (2026). Deuterium magnetic resonance imaging of tumors using low-dose systemic deuterated water labeling. Frontiers in Oncology. 15. 1688968–1688968.
2.
Humphrey, K., Eduardo Cortes Gomez, Vishnu Kumarasamy, et al.. (2025). Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. Molecular Cancer. 24(1). 208–208.
3.
Kim, Minsuh, Eduardo Cortes Gomez, Jianmin Wang, et al.. (2024). CPSF3 inhibition blocks pancreatic cancer cell proliferation through disruption of core histone mRNA processing. RNA. 30(3). 281–297. 6 indexed citations
4.
Attwood, Kristopher, Janusz Franco‐Barraza, Mukund Seshadri, et al.. (2023). Lorazepam Stimulates IL6 Production and Is Associated with Poor Survival Outcomes in Pancreatic Cancer. Clinical Cancer Research. 29(18). 3793–3812. 21 indexed citations
5.
Alam, Shamshad, et al.. (2022). Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth. Molecular Cancer Research. 20(12). 1751–1762. 15 indexed citations
6.
Natale, Christopher A., Sung Hoon Kim, Yiliang Wei, et al.. (2022). Endogenous DOPA inhibits melanoma through suppression of CHRM1 signaling. Science Advances. 8(35). eabn4007–eabn4007. 14 indexed citations
7.
Feigin, Michael E., et al.. (2021). Drivers of Gene Expression Dysregulation in Pancreatic Cancer. Trends in cancer. 7(7). 594–605. 15 indexed citations
8.
Maurer, H. Carlo, et al.. (2020). Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma. Genome Research. 30(3). 347–360. 46 indexed citations
9.
Feigin, Michael E., et al.. (2020). Unintended Effects of GPCR-Targeted Drugs on the Cancer Phenotype. Trends in Pharmacological Sciences. 41(12). 1006–1022. 16 indexed citations
10.
Insel, Paul A., Krishna Sriram, Shu Z. Wiley, et al.. (2018). GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets. Frontiers in Pharmacology. 9. 431–431. 95 indexed citations
11.
Feigin, Michael E., Tyler H. Garvin, Peter J. Bailey, et al.. (2017). Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma. Nature Genetics. 49(6). 825–833. 41 indexed citations
12.
Feigin, Michael E. & David A. Tuveson. (2016). Challenges and Opportunities in Modeling Pancreatic Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 81. 231–235. 11 indexed citations
13.
Feigin, Michael E., S. Dipikaa Akshinthala, Kiyomi Y. Araki, et al.. (2014). Mislocalization of the Cell Polarity Protein Scribble Promotes Mammary Tumorigenesis and Is Associated with Basal Breast Cancer. Cancer Research. 74(11). 3180–3194. 96 indexed citations
14.
Feigin, Michael E., Bin Xue, Molly Hammell, & Senthil K. Muthuswamy. (2014). G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion. Proceedings of the National Academy of Sciences. 111(11). 4191–4196. 66 indexed citations
15.
Feigin, Michael E.. (2013). Harnessing the genome for characterization of G‐protein coupled receptors in cancer pathogenesis. FEBS Journal. 280(19). 4729–4738. 26 indexed citations
16.
Chatterjee, Samit, Michael E. Feigin, Don L. Gibbons, et al.. (2012). Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells. PLoS ONE. 7(4). e34343–e34343. 30 indexed citations
17.
Feigin, Michael E. & Senthil K. Muthuswamy. (2009). Polarity proteins regulate mammalian cell–cell junctions and cancer pathogenesis. Current Opinion in Cell Biology. 21(5). 694–700. 75 indexed citations
18.
Feigin, Michael E. & Craig C. Malbon. (2008). OSTM1 regulates β-catenin/Lef1 interaction and is required for Wnt/β-catenin signaling. Cellular Signalling. 20(5). 949–957. 25 indexed citations
19.
Feigin, Michael E. & Senthil K. Muthuswamy. (2008). ErbB receptors and cell polarity: New pathways and paradigms for understanding cell migration and invasion. Experimental Cell Research. 315(4). 707–716. 36 indexed citations
20.
Bikkavilli, Rama Kamesh, Michael E. Feigin, & Craig C. Malbon. (2008). p38 mitogen-activated protein kinase regulates canonical Wnt–β-catenin signaling by inactivation of GSK3β. Journal of Cell Science. 121(21). 3598–3607. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tadahiro Nagaoka Breakdown of academic impact, for papers by Agata Zieba Breakdown of academic impact, for papers by Angela Russo Breakdown of academic impact, for papers by Xianghu Qu Breakdown of academic impact, for papers by Satoko Ito Breakdown of academic impact, for papers by Anthony Makkinje Breakdown of academic impact, for papers by María Élida Scassa Breakdown of academic impact, for papers by Hashem A. Dbouk Breakdown of academic impact, for papers by Georgia Mavria Breakdown of academic impact, for papers by Delphine Fessart
Rankless by CCL
2026